Strengthening Pharmaceutical Systems (SPS)

The mandate of SPS is to improve access to and use of medicines and health commodities of assured quality for priority health interventions, with a focus on assuring effective pharmaceutical services to achieve desired health outcomes.

The new international health environment, characterized by ambitious treatment targets and vastly increased resources for medicines, poses unique challenges but offers unprecedented opportunities for health program development. SPS employs innovative approaches to strengthen pharmaceutical systems and foster south-tosouth capacity building.

In the pharmaceutical governance arena, SPS advances the USG agenda, including combating corruption, promoting transparency and accountability, and strengthening regulatory capacity to protect public health. Addressing the growing threat posed by accelerating antimicrobial resistance (AMR) is also a major area of work.

Continuing the technical leadership agenda of the RPM Plus Program, SPS provides pharmaceutical management support to global health initiatives, enables donor coordination, facilitates harmonization of tools, and disseminates best practices.